- Home
- BFRI vs PAVM Comparison
BFRI vs PAVM Comparison
Compare BFRI & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | PAVM |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 8.5M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BFRI | PAVM |
|---|---|---|
| Price | $0.82 | $6.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.75 | ★ $510.00 |
| AVG Volume (30 Days) | ★ 424.7K | 32.3K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,164,000.00 | $29,000.00 |
| Revenue This Year | $9.70 | N/A |
| Revenue Next Year | $10.97 | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.11 | N/A |
| 52 Week Low | $0.54 | $6.00 |
| 52 Week High | $1.24 | $26.85 |
Technical Indicators
Market Signals| Indicator | BFRI | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 65.45 |
| Support Level | $0.77 | $6.26 |
| Resistance Level | $0.86 | $9.28 |
| Average True Range (ATR) | 0.08 | 0.88 |
| MACD | 0.01 | 0.30 |
| Stochastic Oscillator | 83.64 | 72.11 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.